Mobley Clinical Research Center
Houston, Texas, 77024, United States
NCT Number: NCT00700505
To determine the safety and efficacy of the ThermaRx heating device for the application of controlled low level heat to improve symptoms of LUT dysfunction (hesitancy, urgency).
Looking for future studies?
Notify Me25 year–80 year
Male
Interventional
Not applicable
Houston, Texas, 77024, United States
This study will assess the safety and efficacy of ThermaRx heat treatment in subjects who have urinary hesitancy.
The rationale for this approach is based on anecdotal evidence and case reports suggesting that urinary hesitancy can be effectively reduced by external skin heating (hot tub "Jacuzzi" effect, perineal hot water spray). However, to date, there have been no formal studies of this non-invasive form of treatment, and the mechanism of action is still unclear.
This is a two-day study in which each subject will receive an oral fluid load and then one (1) heating treatment with the device. Ultrasound-based measurements of bladder volume will be performed both before and after voiding. On Day 1, voiding will be performed in a standing position; on Day 2, voiding will be done in a sitting position.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The garment is shaped like a pair of boxer briefs. Garment heating is battery-powered.
The garment is activated and begins to heat up 5-15 minutes prior to voiding.
Time frame: Both Study Day 1 & 2 before/after oral fluid load
Time frame: Both Study Day 1 & 2 before/after oral fluid load
ThermaRx, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04266418
Benign Prostatic Hyperplasia (BPH), Genital Diseases
Taipei, Taiwan
View Trial DetailsNCT05785286
Benign Prostatic Hyperplasia (BPH), Genital Diseases
Hong Kong
View Trial DetailsNCT02026908
Benign Prostatic Hyperplasia (BPH), Genital Diseases
Chicago, Illinois, United States
View Trial DetailsNCT04681625
Benign Prostatic Hyperplasia (BPH), Female Urogenital Diseases
Martin, Slovakia
View Trial Details